Dhara Rana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dhara Rana has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Fred Berlin
Department of Interventional Radiology, St. Joseph's University Medical Center, Paterson, NJ, USA
2 shared publications- Jamshed Zuberi
Department of Surgery, St. Joseph's University Medical Center, Paterson, NJ, USA
2 shared publications Sayali Kulkarni
Department of Surgery, St. Joseph's University Medical Center, Paterson, NJ, USA
2 shared publicationsAnson Marsh
Department of Internal Medicine, Inspira Medical Center Vineland, Vineland, NJ, USA
1 shared publicationBenjamin Rebein
Department of Surgery, St. Joseph's University Medical Center, Paterson, NJ, USA
1 shared publication- Carlos Rodriguez
Cardiologic Hospital, Lyon, France
1 shared publication
Latest Publications
- Open Access
- 9 July 2024
- Published by Elsevier in JEM Reports
- Vol. 3 (3)
Page kidney induced emergent hypertension status post renal biopsy a case report
- 9 July 2024
- Published by Elsevier in JEM Reports
- Vol. 3 (3)
Open AccessPage kidney induced emergent hypertension status post renal biopsy a case report
- Open Access
- 23 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e24413
Atypical Case of Lyme Neuroborreliosis With Hyponatremia
Lyme neuroborreliosis is diagnostically challenging because of its diverse manifestations. Literatures studies have documented a neurological spectrum that includes radiculoneuritis, lymphocytic meningitis, and cranial neuropathy in the early disseminated stage of Lyme’s disease. Severe and refractory hyponatremia is a rare association with Lyme neuroborreliosis, further misleading clinicians to misdiagnose the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This case report describes a 58-year-old woman who developed progressive lower extremity weakness and paresthesia, cerebellar ataxia, and persistent hyponatremia. The patient was hospitalized to rule out cerebral vascular stroke, Guillain-Barre, and SIADH. Lyme neuroborreliosis was diagnosed and treated with 2mg ceftriaxone from clinical suspicion. With treatment initiation, the patient’s neurological symptoms of gait instability, hyponatremia, and bilateral lower extremities weakness gradually resolved.
- 23 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e24413
Open AccessAtypical Case of Lyme Neuroborreliosis With Hyponatremia
Lyme neuroborreliosis is diagnostically challenging because of its diverse manifestations. Literatures studies have documented a neurological spectrum that includes radiculoneuritis, lymphocytic meningitis, and cranial neuropathy in the early disseminated stage of Lyme’s disease. Severe and refractory hyponatremia is a rare association with Lyme neuroborreliosis, further misleading clinicians to misdiagnose the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This case report describes a 58-year-old woman who developed progressive lower extremity weakness and paresthesia, cerebellar ataxia, and persistent hyponatremia. The patient was hospitalized to rule out cerebral vascular stroke, Guillain-Barre, and SIADH. Lyme neuroborreliosis was diagnosed and treated with 2mg ceftriaxone from clinical suspicion. With treatment initiation, the patient’s neurological symptoms of gait instability, hyponatremia, and bilateral lower extremities weakness gradually resolved.
- Open Access
- 3 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e23782
A Case Report: Ethambutol Causes a Rare Adverse Effect of Peripheral Neuropathy
Mycobacterium gordonae is a slow-growing acid-fast bacilli mycobacterium with low pathogenic potential. Patients with this infection are treated with antimycobacterial agents such as ethambutol, clarithromycin, and rifampin. We present a rare side effect of ethambutol causing peripheral neuropathy, along with regression of this upon discontinuation of the inciting medication. A 78-year-old male with a past medical history of lumbar degenerative disc disease and lumbosacral radiculopathy presented to the clinic with three weeks of progressively worsening rhinorrhea, nasal congestion, and productive cough with yellow sputum. After a bronchoalveolar lavage (BAL) and a chest computed tomography (CT) scan, he was diagnosed with an M. gordonae infection. He was started on a 12-month triple regimen of rifampin, clarithromycin, and high-dose ethambutol. During the first three months of antibiotic therapy, the patient began to have symptoms of gastrointestinal upset and worsening numbness in bilateral lower extremities, especially at night. Because he was unable to tolerate these adverse effects, the patient stopped taking these medications three months into his 12-month course. Upon stopping the antimycobacterial therapy, the patient’s neuropathy began to return to baseline. Based on imaging, electromyography (EMG), nerve conduction studies (NCS), and a literature search of antimycobacterial medicines, we concluded that the high dose of ethambutol is the most likely cause of this patient’s peripheral neuropathy. An important takeaway is that while ethambutol is a well-known cause of optic neuritis, it may also lead to peripheral neuropathy, which may regress upon discontinuation of the medication.
- 3 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e23782
Open AccessA Case Report: Ethambutol Causes a Rare Adverse Effect of Peripheral Neuropathy
Mycobacterium gordonae is a slow-growing acid-fast bacilli mycobacterium with low pathogenic potential. Patients with this infection are treated with antimycobacterial agents such as ethambutol, clarithromycin, and rifampin. We present a rare side effect of ethambutol causing peripheral neuropathy, along with regression of this upon discontinuation of the inciting medication. A 78-year-old male with a past medical history of lumbar degenerative disc disease and lumbosacral radiculopathy presented to the clinic with three weeks of progressively worsening rhinorrhea, nasal congestion, and productive cough with yellow sputum. After a bronchoalveolar lavage (BAL) and a chest computed tomography (CT) scan, he was diagnosed with an M. gordonae infection. He was started on a 12-month triple regimen of rifampin, clarithromycin, and high-dose ethambutol. During the first three months of antibiotic therapy, the patient began to have symptoms of gastrointestinal upset and worsening numbness in bilateral lower extremities, especially at night. Because he was unable to tolerate these adverse effects, the patient stopped taking these medications three months into his 12-month course. Upon stopping the antimycobacterial therapy, the patient’s neuropathy began to return to baseline. Based on imaging, electromyography (EMG), nerve conduction studies (NCS), and a literature search of antimycobacterial medicines, we concluded that the high dose of ethambutol is the most likely cause of this patient’s peripheral neuropathy. An important takeaway is that while ethambutol is a well-known cause of optic neuritis, it may also lead to peripheral neuropathy, which may regress upon discontinuation of the medication.
- Open Access
- 21 March 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (5) , 1692-1695
Novel method of using angioembolization for treating testicular hemorrhage after blunt trauma
- 21 March 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (5) , 1692-1695
Open AccessNovel method of using angioembolization for treating testicular hemorrhage after blunt trauma
- Open Access
- 31 December 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (3) , 816-820
Frontal subcutaneous lipoma associated with large interhemispheric lipoma and corpus callosum agenesis
- 31 December 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (3) , 816-820
Open AccessFrontal subcutaneous lipoma associated with large interhemispheric lipoma and corpus callosum agenesis